An engineered nano-liposome-human ACE2 decoy neutralizes SARS-CoV-2 Spike protein-induced inflammation in both murine and human macrophages
Open Access
- 1 January 2022
- journal article
- research article
- Published by Ivyspring International Publisher in Theranostics
- Vol. 12 (6) , 2639-2657
Abstract
Rationale: Macrophages are the frontline immune cells in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Angiotensin-converting enzyme 2 (ACE2) serves as the binding receptor to SARS-CoV-2 Spike glycoprotein for fusion and internalization into the human host cells. However, the mechanisms underlying SARS-CoV-2-elicited macrophage inflammatory responses remain elusive. Neutralizing SARS-COV-2 by human ACE2 (hACE2) decoys has been proposed as a therapeutic approach to ameliorate SARS-CoV-2-stimulated inflammation. This study aims to investigate whether an engineered decoy receptor can abrogate SARS-CoV-2-induced macrophage inflammation.Keywords
This publication has 67 references indexed in Scilit:
- Myeloid-Specific IκB Kinase β Deficiency Decreases Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Single Sample Expression-Anchored Mechanisms Predict Survival in Head and Neck CancerPLOS Computational Biology, 2012
- High-Throughput Illumina Strand-Specific RNA Sequencing Library PreparationCold Spring Harbor Protocols, 2011
- Macrophages in the Pathogenesis of AtherosclerosisCell, 2011
- NF-κB, Inflammation, and Metabolic DiseaseCell Metabolism, 2011
- Comprehensive comparative analysis of strand-specific RNA sequencing methodsNature Methods, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Shared Principles in NF-κB SignalingCell, 2008
- Signaling to NF-κB by Toll-like receptorsTrends in Molecular Medicine, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001